|
US2007060537A1
|
|
Methods and compositions for inhibiting viral infections
|
|
US2006233779A1
|
|
Ring finger family proteins and uses related thereto
|
|
US2009263821A1
|
|
Ubiquitin Ligase Assays And Related Reagents
|
|
US2006287337A1
|
|
Trans-golgi network-associated processes, methods and compositions related thereto
|
|
WO2005038007A2
|
|
Posh and associated proteins
|
|
WO2005007141A2
|
|
Ubiquitin ligase inhibitors and methods related thereto
|
|
EP1631825A2
|
|
Pem-3-like compositions and related methods thereof
|
|
WO2004089302A2
|
|
Posh polypeptides, complexes and related methods
|
|
WO2004099388A2
|
|
Cbl-b polypeptides, complexes and related methods
|
|
US2006286630A1
|
|
Posh interacting proteins and related methods
|
|
AU2004218430A1
|
|
Posh interacting proteins and related methods
|
|
WO2004073609A2
|
|
Posh associated kinases and related methods
|
|
WO2004098492A2
|
|
Trans-golgi network-associated processes, methods and compositions related thereto
|
|
AU2003304109A1
|
|
Trans-golgi network-associated processes, methods and compositions related thereto
|
|
AU2003218225A8
|
|
Posh nucleic acids, polypeptides and related methods
|
|
AU2003202918A1
|
|
Methods and compositions for isoelectric focusing
|
|
WO03051835A2
|
|
Methods and compositions for the inhibition of viral release
|
|
IL162062D0
|
|
Methods for identifying and validating potential drug targets
|
|
EP1310552A2
|
|
Posh nucleic acids, polypeptides and related methods
|
|
AU2002365189A1
|
|
P85-alpha nucleic acids, polypeptides and related methods
|
